{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    4,
    5,
    6,
    10,
    11,
    12,
    13,
    14,
    29,
    30,
    31,
    32,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "AZD7442",
        "type": {
          "id": "eddb7945-f364-423d-b75a-1f8ddac7a80e",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "1fc77a07-e1c4-40f4-aa73-06c98ea98aa2",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "A combination product of 2 monoclonal antibodies (AZD8895 and AZD1061) for the treatment of COVID-19.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Saline placebo",
        "type": {
          "id": "34b40fb3-97a9-46b1-99ab-4a89025b71fa",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "role": {
          "id": "786c4844-7c8c-489e-b83a-5ce3ed9bf514",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Visually distinct saline solution administered as 2 separate 3 mL IM injections.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Local standard of care",
        "type": {
          "id": "62c04613-af8b-474c-a061-1ff32db036a5",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "6a680019-c74e-4fbf-9451-df6f000d8511",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Background therapy according to participating institution/hospital regardless of randomization group.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Influenza vaccines",
        "type": {
          "id": "04d4352a-1269-409f-b996-7e5528f3b211",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "a142e3d3-45c5-49bc-853d-3d813bcc2657",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Licensed influenza vaccines are permitted at any time.",
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Allergen immunotherapy",
        "type": {
          "id": "d17dda13-60e7-41d3-8574-cd33610316b2",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "ad598554-96a0-4af6-8025-45a809264b06",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Allowed if participant has been receiving stable desensitization therapy for at least 30 days prior to Day 1."
      },
      {
        "id": "int_6",
        "name": "Commercial biologics/immunosuppressants",
        "type": {
          "id": "26d0149e-63f7-4fd4-bfec-6c2ba021c587",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "aae04ab7-5703-45f1-b695-f1aeeeeff3f7",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Includes prednisone, azathioprine, tacrolimus, cyclosporine, methotrexate, hydroxychloroquine, or cytotoxic chemotherapy if stable on maintenance dose."
      },
      {
        "id": "int_7",
        "name": "SARS-CoV-2 vaccines",
        "type": {
          "id": "bcf4853a-09b6-4592-9f17-24795d230c84",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "cd877296-2c22-441c-9a47-dc5619cd7044",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited prior to study entry; restricted during acute illness; requires unblinding and counseling if requested after recovery."
      },
      {
        "id": "int_8",
        "name": "Convalescent COVID-19 plasma",
        "type": {
          "id": "7fe7df67-385f-435c-a506-bcb69459c3e4",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "0d72fd2c-aa46-4dbe-82dc-c64c9d67601b",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited at any time prior to study entry."
      },
      {
        "id": "int_9",
        "name": "Systemic or inhaled steroids",
        "type": {
          "id": "bc421e92-98c1-4f5c-b7f5-45d6866fc2d5",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "8f306241-4f4d-4e1d-b6b7-0a5a687d8767",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 30 days prior to study entry unless a stable dose is used for a chronic condition."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "AZD8895",
        "administrableDoseForm": {
          "id": "ea34b254-4b78-4303-9c52-9d2ca6e66ad0",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "5b833b02-0d8f-415c-93c2-cc2362040739",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "0f061809-063e-4eb8-979a-d87966f60758",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "100 mg/mL",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "AstraZeneca"
      },
      {
        "id": "prod_2",
        "name": "AZD1061",
        "administrableDoseForm": {
          "id": "8f5cebc6-902c-4704-b872-c7487482701f",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "17bfe197-4a58-436f-b855-d9fa0cff19f0",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "caf7bdea-7b75-4fb1-9d72-bf6f7fac51a0",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "100 mg/mL",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "AstraZeneca"
      },
      {
        "id": "prod_3",
        "name": "Saline placebo",
        "administrableDoseForm": {
          "id": "3479c948-ceea-4a70-924a-8d446e536933",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "b7bc3215-385a-4d67-98c7-5146b9a8781a",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "7f553253-2e5d-457c-86c5-26a8cada1a93",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "0.9% w/v",
        "manufacturer": "AstraZeneca"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "AZD7442 600 mg IM",
        "instanceType": "Administration",
        "dose": "600 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Day 1 only (monitored for 456 days)"
      },
      {
        "id": "admin_2",
        "name": "AZD8895 component",
        "instanceType": "Administration",
        "dose": "300 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Administered as a 3 mL injection in the gluteal region"
      },
      {
        "id": "admin_3",
        "name": "AZD1061 component",
        "instanceType": "Administration",
        "dose": "300 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Administered as a 3 mL injection in the gluteal region"
      },
      {
        "id": "admin_4",
        "name": "Placebo administration",
        "instanceType": "Administration",
        "dose": "6 mL total",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Two separate 3 mL injections in the gluteal region"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "AZD8895",
        "instanceType": "Substance",
        "description": "Monoclonal antibody component of AZD7442"
      },
      {
        "id": "sub_2",
        "name": "AZD1061",
        "instanceType": "Substance",
        "description": "Monoclonal antibody component of AZD7442"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 9,
      "productCount": 3,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "AZD7442",
        "role": "Investigational Product",
        "description": "A combination product of 2 monoclonal antibodies (AZD8895 and AZD1061) for the treatment of COVID-19."
      },
      {
        "name": "Saline placebo",
        "role": "Placebo",
        "description": "Visually distinct saline solution administered as 2 separate 3 mL IM injections."
      },
      {
        "name": "Local standard of care",
        "role": "Background Therapy",
        "description": "Background therapy according to participating institution/hospital regardless of randomization group."
      },
      {
        "name": "Influenza vaccines",
        "role": "Concomitant Medication",
        "description": "Licensed influenza vaccines are permitted at any time."
      },
      {
        "name": "Allergen immunotherapy",
        "role": "Concomitant Medication",
        "description": "Allowed if participant has been receiving stable desensitization therapy for at least 30 days prior to Day 1."
      },
      {
        "name": "Commercial biologics/immunosuppressants",
        "role": "Concomitant Medication",
        "description": "Includes prednisone, azathioprine, tacrolimus, cyclosporine, methotrexate, hydroxychloroquine, or cytotoxic chemotherapy if stable on maintenance dose."
      },
      {
        "name": "SARS-CoV-2 vaccines",
        "role": "Concomitant Medication",
        "description": "Prohibited prior to study entry; restricted during acute illness; requires unblinding and counseling if requested after recovery."
      },
      {
        "name": "Convalescent COVID-19 plasma",
        "role": "Concomitant Medication",
        "description": "Prohibited at any time prior to study entry."
      },
      {
        "name": "Systemic or inhaled steroids",
        "role": "Concomitant Medication",
        "description": "Prohibited within 30 days prior to study entry unless a stable dose is used for a chronic condition."
      }
    ],
    "products": [
      {
        "name": "AZD8895",
        "doseForm": "Injection",
        "strength": "100 mg/mL",
        "manufacturer": "AstraZeneca"
      },
      {
        "name": "AZD1061",
        "doseForm": "Injection",
        "strength": "100 mg/mL",
        "manufacturer": "AstraZeneca"
      },
      {
        "name": "Saline placebo",
        "doseForm": "Injection",
        "strength": "0.9% w/v",
        "manufacturer": "AstraZeneca"
      }
    ],
    "substances": [
      {
        "name": "AZD8895",
        "description": "Monoclonal antibody component of AZD7442"
      },
      {
        "name": "AZD1061",
        "description": "Monoclonal antibody component of AZD7442"
      }
    ],
    "administrations": [
      {
        "name": "AZD7442 600 mg IM",
        "dose": "600 mg",
        "frequency": "Single dose",
        "route": "Intramuscular",
        "duration": "Day 1 only (monitored for 456 days)"
      },
      {
        "name": "AZD8895 component",
        "dose": "300 mg",
        "frequency": "Single dose",
        "route": "Intramuscular",
        "duration": "Administered as a 3 mL injection in the gluteal region"
      },
      {
        "name": "AZD1061 component",
        "dose": "300 mg",
        "frequency": "Single dose",
        "route": "Intramuscular",
        "duration": "Administered as a 3 mL injection in the gluteal region"
      },
      {
        "name": "Placebo administration",
        "dose": "6 mL total",
        "frequency": "Single dose",
        "route": "Intramuscular",
        "duration": "Two separate 3 mL injections in the gluteal region"
      }
    ],
    "devices": []
  }
}